<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peng F</submitter><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</funding><pagination>1636</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12905394</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>Single-cell RNA sequencing (scRNA-seq) has identified intermediate epithelial states in pulmonary fibrosis, including KRT5-/KRT17+ aberrant basaloid cells in humans and Krt8+ alveolar differentiation intermediates (ADIs) in mice. Their functional contributions to fibrogenesis, however, remain unclear. Here, we introduce an RNA-sensing-dependent protein translation technology that enables selective targeting of Krt8+ ADI cells in vitro and in vivo. Transcriptomic analysis revealed Small Proline-Rich Protein 1 A (SPRR1A) mRNA as a shared marker of murine Krt8+ ADIs and human KRT5-/KRT17+ basaloid cells, distinguishing them from other lung cell populations. Using programmable RNA sensors, we demonstrated selective EGFP-labeling of Krt8+ ADI cells in vivo, which faithfully recapitulated their </pubmed_abstract><journal>Nature communications</journal><pubmed_title>Transcriptomic signature-guided depletion of intermediate alveolar epithelial cells ameliorates pulmonary fibrosis in mice.</pubmed_title><pmcid>PMC12905394</pmcid><funding_grant_id>R01 HL156973</funding_grant_id><funding_grant_id>R01 HL139584</funding_grant_id><funding_grant_id>HL174994</funding_grant_id><funding_grant_id>R01 HL174994</funding_grant_id><funding_grant_id>HL156973</funding_grant_id><funding_grant_id>HL139584</funding_grant_id><pubmed_authors>Saito S</pubmed_authors><pubmed_authors>Zheng Z</pubmed_authors><pubmed_authors>He C</pubmed_authors><pubmed_authors>Rosas IO</pubmed_authors><pubmed_authors>Aliyari S</pubmed_authors><pubmed_authors>Lasky JA</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Shan D</pubmed_authors><pubmed_authors>Thannickal VJ</pubmed_authors><pubmed_authors>Peng F</pubmed_authors><pubmed_authors>Sabharwal A</pubmed_authors><pubmed_authors>Yin Q</pubmed_authors><pubmed_authors>Jiang CS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptomic signature-guided depletion of intermediate alveolar epithelial cells ameliorates pulmonary fibrosis in mice.</name><description>Single-cell RNA sequencing (scRNA-seq) has identified intermediate epithelial states in pulmonary fibrosis, including KRT5-/KRT17+ aberrant basaloid cells in humans and Krt8+ alveolar differentiation intermediates (ADIs) in mice. Their functional contributions to fibrogenesis, however, remain unclear. Here, we introduce an RNA-sensing-dependent protein translation technology that enables selective targeting of Krt8+ ADI cells in vitro and in vivo. Transcriptomic analysis revealed Small Proline-Rich Protein 1 A (SPRR1A) mRNA as a shared marker of murine Krt8+ ADIs and human KRT5-/KRT17+ basaloid cells, distinguishing them from other lung cell populations. Using programmable RNA sensors, we demonstrated selective EGFP-labeling of Krt8+ ADI cells in vivo, which faithfully recapitulated their </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T22:10:17.526Z</modification><creation>2026-07-09T10:19:59.896Z</creation></dates><accession>S-EPMC12905394</accession><cross_references><pubmed>41519994</pubmed><doi>10.1038/s41467-026-68354-y</doi></cross_references></HashMap>